Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proshares Trust (ZBIO) Revenue (2023 - 2025)

Historic Revenue for Zenas BioPharma (ZBIO) over the last 3 years, with Q1 2025 value amounting to $10.0 million.

  • Zenas BioPharma's Revenue changed N/A to $10.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is 9000.0% down from last year.
  • Latest data reveals that Zenas BioPharma reported Revenue of $10.0 million as of Q1 2025.
  • Zenas BioPharma's Revenue's 5-year high stood at $50.0 million during Q3 2023, with a 5-year trough of $5.0 million in Q4 2024.
  • In the last 3 years, Zenas BioPharma's Revenue had a median value of $10.0 million in 2025 and averaged $21.7 million.